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Date Weight 28kg Study: VILI VILI Worksheet
Pig # 2334 Length 38" Group: Control
Time HR BP RR Ppk Ppl Pm PEEP aPEEP WOB TV EMV Ri Re Comp FiO2 CVP PAP PAOP CO REF Temp Fluid UOP Hgb
A Baseline 9:45 152 124 14 39 21 7.9 3 279 3.9 5 10 14.6 1 5 19 8 5.71 42 36 12.8 99
V 12.8
A T0 10:15 113 134 14 18 16 6.6 2.4 269 3.8 23 15.5 1 5 17 7 4.8 36 12.6
V 12.7
A T30 10:45 120 140 14 20 18 7.1 2.4 282 4 20 16.8 1 5 18 7 3.95 38 35.6 13.1
V 12.9
A T60 11:15 117 127 14 20 18 6.7 2.9 262 3.8 11 15.9 1 5 22 7 3.83 21 35.7 200 13.8
V 13.9
A T90 11:45 114 119 16 19 17 6.5 3.3 265 3.8 8 4 19.9 1 5 16 6 3.73 27 35.9 14
V 13.8
A T120 12:15 121 122 14 18 16 6.2 3.4 265 3.8 6 3 19.5 1 5 22 6 4.44 20 36 400 11.1
V 12.1
A T150 12:45 121 123 14 20 18 7.1 2.5 269 3.8 17 14.8 1 5 22 7 3.85 19 36.1 200 12.1
V 13.7
A T180 13:15 102 121 14 19 17 6.3 4.3 264 3.7 9 3 19 1 4 24 7 2.68 20 36.6 12.8
V 14.1
A T210 13:45 94 151 14 17 15 6.2 3.2 269 3.8 7 4 22.4 1 5 31 9 2.23 21 36.8 75 12.6
V 14.4
A T240 14:15 93 115 14 17 16 6.5 3.1 266 3.8 9 3 21.5 1 5 26 8 2.66 24 36.6 14,5
V 14.7
A T270 14:45 92 117 14 18 16 6.6 3 289 3.9 10 3 21.6 1 4 29 8 2.08 18 37 110 14.4
V 14.6
A T300 15:15 90 124 14 20 18 7.2 3 300 4.2 10 7 22.7 1 6 39 9 2.11 17 37.2 14.1
V 14.7
A T330 15:45 107 117 14 19 18 7.1 3 304 4.2 11 6 22 1 7 31 10 2.23 20 37.3 150 13.2
V 14.5
A T360
V
A T375 16:00 136 129 14 17 16 6.6 2.9 308 4.3 9 5 25.6 14.8
V 14.5
Notes:
Return to 12 cc/kg PEEP 3 for 15"  to check Blood Gases and Mechanics
Baseline and T0 are identical in control: no need for additional reading.  T0 in injury is immediately following injury.
01/25/06
Date Weight 20kg Study: VILI VILI Worksheet
Pig # 2335 Length 38" Group: Control
Time HR BP RR Ppk Ppl Pm PEEP aPEEP WOB TV EMV Ri Re Comp FiO2 CVP PAP PAOP CO REF Temp Fluid UOP Hgb
A Baseline 11:30 114 115 15 22 20 7.5 3 1.3 0 369 4.9 3 8 23.9 1 3 24 10 2.15 20 36.7 700 14
V 14.9
A T0 12:00 162 150 15 28 25 9.6 3 1.3 351 5.3 6 13 16.9 1 11 10 9 1.2 18 36.5 400 14.2
V 14.6
A T30 12:30 142 132 15 25 23 9 3 0.5 352 5.3 7 11 18.9 1 10 29 8 1.49 19 36.5 200 1300 16.1
V 16.3
A T60 13:00 84 119 15 25 22 8.8 3 0.7 345 5.2 7 11 19.2 1 3 36 8 1.41 15 36.4 100 200 17.1
V 17.4
A T90 13:30 77 117 15 26 23 9.1 3 1 363 5.4 6 11 19.3 1 4 35 9 1.57 20 36.4 100 60 17.1
V 17.3
A T120 14:00 92 122 12 26 23 8.1 3 0.9 359 4.6 7 11 19 1 3 37 8 1.11 14 36.4 50 8 18
V 15.2
A T150 14:30 99 120 12 27 24 8.2 3 0.7 354 4.3 7 12 18.3 1 3 36 9 2.09 13 36.5 50 6 15.8
V 14.5
A T180 15:00 105 120 12 28 25 8.4 3 0.7 355 4.3 6 12 17.8 1 4 39 9 2.43 13 36.4 50 5 15.7
V 17
A T210 15:30 86 142 12 24 22 7.8 3 0.8 364 4.4 10 10 20.2 1 4 40 10 2.44 16 36.2 120 24 13.7
V 14.1
A T240 16:00 94 122 12 28 25 8.7 3.1 0.5 364 4.7 9 11 20 1 3 41 8 2.68 13 36.3 100 29 14.8
V 15.4
A T270 16:30 128 126 14 27 24 9.1 3.1 0.6 355 5 9 12 18.2 1 4 42 8 1.47 13 36.4 60 18 15.5
V 16.3
A T300 17:00 109 120 14 29 26 9.6 3 1.1 364 5.1 8 12 16.5 1 4 39 8 1.79 13 36.5 0 26 16.7
V 15.7
A T330 17:30 112 115 14 29 26 9.6 3 0.2 386 5.4 7 10 16.5 1 4 35 9 2.15 17 36.5 0 22 15.9
V 17.3
A T360 18:00 106 123 14 23 20 8 3.1 0.5 348 4.8 9 10 21.5 1 3 38 8 1.99 13 36.8 0 16.4
V 17.1
A T375 18:15 N/A N/A 14 25 22 9.1 3 0.2 384 5.7 8 3 17.5 1 N/A N/A N/A N/A N/A N/A N/A N/A 16.6
V 17.3
Notes:
Return to 12 cc/kg PEEP 3 for 15"  to check Blood Gases and Mechanics
Baseline and T0 are identical in control: no need for additional reading.  T0 in injury is immediately following injury.
01/30/06
Date Weight 31kg Study: VILI VILI Worksheet
Pig # 2336 Length 41" Group: Control
Time HR BP RR Ppk Ppl Pm PEEP aPEEP WOB TV EMV Ri Re Comp FiO2 CVP PAP PAOP CO REF Temp Fluid UOP Hgb
A Baseline 8:30 109 121 12 19 16 6.4 3 368 4.4 8 9 29.4 1 5 21 8 2.24 34 36.2 200 11.5
V 12.5
A T0
V
A T30 9:00 76 123 12 17 14 6.1 3 0.1 370 4.5 9 8 36 1 7 32 8 3.1 38 35.9 100 14.1
V 14
A T60 9:30 82 134 12 18 15 6.3 3 0 368 4.4 8 9 33 1 6 28 8 3.65 32 35.7 125 200 14.5
V 14.5
A T90 10:00 78 134 12 19 16 6.4 3.1 0.3 376 4.5 8 9 32 1 7 27 8 2.69 38 35.8 100 14.4
V 14.1
A T120 10:30 70 129 12 19 16 6.5 3 0 372 4.4 8 9 30.4 1 6 28 8 2.03 27 35.8 100 50 14.7
V 14.8
A T150 11:00 115 149 12 20 18 6.7 3 0.4 376 4.6 8 10 28.3 1 4 38 9 3.28 29 35.9 100 15.5
V 15.1
A T180 11:30 92 138 12 20 17 6.8 3.1 0 361 4.4 7 10 271 1 5 36 8 2.11 20 36.2 100 75 15.6
V 15.6
A T210 12:00 93 154 12 19 17 6.6 3 0.2 374 4.5 8 10 301 1 6 35 8 2.14 30 36.2 125 16.3
V 16.2
A T240 12:30 90 142 12 20 18 6.8 3 374 4.5 7 10 28.3 1 7 37 10 2.27 21 36.3 50 100 16.2
V 16.4
A T270 13:00 101 138 12 21 18 6.8 3 372 4.5 8 10 26.9 1 7 37 10 2.02 18 36.2 50 15.4
V 16
A T300 13:30 90 147 12 21 17 6.9 3 0 375 4.5 7 11 26.3 1 6 37 10 2.54 25 36.2 125 75 15.7
V 14.7
A T330 14:00 94 144 12 21 19 6.9 3 0 372 4.5 7 11 26.3 1 7 37 9 2.73 24 36.2 125 15.7
V 15.6
A T360 14:30 98 142 12 21 18 6.9 3 0 374 4.5 7 11 26.9 1 7 33 9 2.29 32 36.3 150 15.2
V 15.9
A T375 90 138 12 20 17 6.6 3 369 4.4 8 10 28.9 1 6 35 8 36.4 15.1
V 15.4
Notes:
50 BAL  5 in Para in freezer next door
Return to 12 cc/kg PEEP 3 for 15"  to check Blood Gases and Mechanics
Baseline and T0 are identical in control: no need for additional reading.  T0 in injury is immediately following injury.
02/02/06
Date Weight 23kg Study: Tween Lavage & Dye VILI Worksheet
Pig # 2343 Length 94cm Group: Tween 
Time HR BP RR Ppk Ppl Pm PEEP aPEEP Rcexp Rcinsp TV EMV Ri Re Comp FiO2 CVP PAP PAOP CO REF Temp Fluid UOP Hgb
A Baseline 9:44 185 88 16 19 13 13 3 0 260 4.2 12 11 29.7 0.21 9 32 11 1.54 44 35 575 12.4
V 14.4
A T0 10:15 138 111 13 27 20 10 3 259 4.2  13 16.1 1 9 22 11 2.15 28 34.7 425 14.4
V 14.5
A T30 10:45 165 109 17 30 24 12 2.6 260 4.6 17 7 14.4 1 8 19 9 3.76 28 34.8 0 14.2
V 13.8
A T60 11:15 131 123 16 29 23 10 3 246 4 11 17 13.5 1 8 21 10 1.79 27 35.1 0 50 13.9
V 13.6
A T90 11:45 131 114 20 27 22 12 3.1 261 5.3 10 15 14.3 1 8 20 8 3.06 27 35 0 13.5
V 15.
A T120 12:15 144 108 20 29 25 13 3 251 5.3 9 16 14 1 8 21 10 2.42 29 35 0 200 14.8
V 15.6
A T150 12:45 138 110 20 29 25 13 3 269 5.3 10 16 13.5 1 8 20 10 3.19 33 35.1 0 15.8
V 16.
A T180 13:15:00 114 107 22 27 23 13 3 274 5.9 10 16 14.5 1 9 24 11 2.79 21 35.2 0 75 15.
V 14.6
A T210 13:45:00 85 110 22 27 22 13 3.1 268 5.9 7 17 14.7 1 11 31 13 1.11 28 35.3 20 15.5
V 15.2
A T240 14:15 107 114 22 27 23 12 3.1 271 6 11 16 15.6 1 9 28 11 1.43 24 35.5 0 40 14.8
V 15.4
A T270 14:45 105 104 22 26 22 12 3 272 6 8 16 15.6 1 9 29 13 1.83 24 35.6 0 15.6
V 13.
A T300 15:15 110 105 22 26 22 13 3 271 5.9 8 25 16.4 1 9 30 10 1.36 25 35.6 6 100 12.4
V 13.7
A T330 15:45 111 118 20 27 22 12 3 267 5.3 8 17 15.3 1 8 33 10 1.57 28 35.7 0 14.2
V 14.6
A T360 16:15 118 89 27 28 26 16 3 270 7.3 7 19 14.8 1 9 27 11 1.56 24 35.8 0 15.3
V 14.6
A T375
V
Notes:
Switched tp Pcontrol  PIP 35/PEEP 10  decreased RR about 40% during Tween
Why is PO2 so low without big change in lung mechanics?
Could any injury be due to hypoxia?
Is a single initial injury such as Tween the best model for VILI?
T330  PaCO2>PvCO2 - prob bad gases
1cc Succinylcholine  before PV curve
Return to 12 cc/kg PEEP 3 for 15"  to check Blood Gases and Mechanics
Baseline and T0 are identical in control: no need for additional reading.  T0 in injury is immediately following injury.
03/15/06
Date Weight 23kg Study: VILI VILI Worksheet
Pig # 2344 Length 94cm Group: Tween 
Time HR BP RR Ppk Ppl Pm PEEP aPEEP WOB TV EMV Ri Re Comp FiO2 CVP PAP PAOP CO REF Temp Fluid UOP Hgb
A Baseline 8:25 116 144 12 16 15 6 3 0.2 280 3.4 9 12 23.9 0.21 14 30 11 2.28 35 35.1 550 11
V 11.8
A T0 8:50 99 122 17 34 32 19 3 318 5.6 37 15 10.1 1 7 14 9 2.03 37 34.7 450 13.3
V 14.6
A T30 9:20 85 108 18 31 30 15 3.1 3.4 332 6 26 10 11.8 1 7 21 9 4.49 31 34.4 0 13
V 13.7
A T60 9:50 79 105 18 31 30 14 2.9 277 5 24 15 10 0.4 7 22 10 3.87 28 34 0 150 11.9
V 13.7
A T90 10:20 98 104 18 33 31 14 3 0.4 277 5 20 17 9.9 0.9 6 20 7 4.46 39 33.8 0 13.7
V 13.1
A T120 10:50 125 103 18 35 33 15 3 290 5.3 17 18 10.5 0.9 6 24 8 4.6 25 33.7 0 100 12.6
V 14.2
A T150 11:20 114 104 18 36 34 16 3 268 4.8 26 20 8.6 0.9 5 27 8 4.41 18 33.7 0 14.3
V 14.3
A T180 11:50 81 115 18 36 34 15 3 0.8 266 4.8 19 21 8.7 0.9 5 25 7 4.33 16 33.8 0 40 12.9
V 14.5
A T210 12:20 109 106 18 37 35 16 3 1.1 262 4.8 25 20 8.3 0.8 7 30 9 4.25 15 34.1 0 12.3
V 14.2
A T240 12:50 121 108 18 37 36 16 3.1 0.8 263 4.8 24 21 8.2 0.8 5 31 4.68 26 34.4 0 40 14.5
V 14.6
A T270 13:20 102 109 18 43 41 17 3 0.2 257 4.6 17 24 7.4 0.8 5 31 4.68 26 34.4 0 15.8
V 16.8
A T300 13:50 113 100 22 42 37 17 3 2.2 272 6 23 22 8.4 1 7 34 3.09 18 34.5 0 50 15.3
V 15.2
A T330 14:20 155 97 24 38 37 19 2.9 1.7 277 6.7 21 22 8.4 1 4 30 3.87 21 34.5 0 15.1
V 15.6
A T360 14:50 155 98 24 38 37 19 3.1 1.3 288 6.7 20 23 8.4 1 7 33 2.33 23 34.5 0 20 14.9
V 15.6
A T375
V
Notes:
Return to 12 cc/kg PEEP 3 for 15"  to check Blood Gases and Mechanics
Baseline and T0 are identical in control: no need for additional reading.  T0 in injury is immediately following injury.
03/16/06
Date Weight 21 kg Study VILI: Control/NPV/ARDSnet/HFOV/APRV/Kinetic Wet Wt=
Pig # Anesthesia Typ Group: Dry Wt =
5% Tween W/D ratio=
Dish Weight=
Date Weight 31kg Study: VILI VILI Worksheet
Pig # ### Length 41" Group: Control
Time RR Ppk Ppl Pm TV PEEP
aPEE
P EMV COMP Rcinsp Rcexp Re Ri MAP HR CVP PAP PAOP CO Temp Fluid UOP FiO2 Hgb Sat BE pH pO2 pCO2 Samples
A Baseline 8:50 12 24 21 8.2 218 3 3.1 17 0.12 0.26 9 7 109 9 34 10 6.3 35.6 1000 21 13 94.3 0 7.45 85 34 Cy+P/V
V 13.4 62.6 2 7.42 41 42
A T0 9:30 23 31 29 13 232 3 5.1 8.6 0.18 0.23 14 21 116 160 8 30 9 6.79 35.2 100 12.7 87.7 1 7.43 64 38 Cy +P/V
V 14.3 54.4 2 7.4 39 45
A T30 10:00 23 31 29 13 229 3 2 5.1 8.6 0.14 0.2 13 15 111 160 6 25 9 4.85 34.6 40 100 14.5 75.8 3 7.44 77 40
V 14.4 41.5 3 7.4 32 46
A T60 10:30 23 32 31 13 232 3 1.5 5.1 7.6 0.08 0.19 15 10 108 143 6 24 9 3.86 34 70 100 14.5 71.1 2 7.43 46 40 Cy
V 14.6 39.1 3 7.4 30 45
A T90 11:00 23 34 32 14 236 3.1 1.9 5.1 7.4 0.07 0.19 16 11 109 139 6 23 8 3.31 33.9 40 100 15.1 79.6 3 7.45 52 39
V 15 46.5 3 7.4 35 46
A T120 11:30 23 34 32 14 229 3 1.8 5 7.3 0.09 0.2 17 11 114 145 6 29 8 2.9 33.8 100 16 100 15 81.5 2 7.45 54 37 Cy
V 14.9 39.2 3 7.42 31 44
A T150 12:00 23 34 32 18 224 3 2.1 4.9 6.9 0.1 0.2 17 13 107 158 8 39 12 2.87 33.8 100 6 100 14.8 77.2 1 7.44 49 36
V 15.1 33.5 3 7.4 28 46
A T180 12:30 23 35 32 15 222 3.1 2.4 4.9 6.7 0.11 0.2 22 18 106 175 8 35 10 2.18 33.8 300 50?? 100 15.4 68.9 1 7.42 46 39 Cy+P/V
V 15.5 25.1 2 7.38 26 47
A T210 13:00 23 35 33 12 218 3 1.1 4.8 6.3 0.11 0.19 19 18 103 177 8 17 9 2.94 33.8 4 100 15.4 68.9 1 7.38 47 41
V 14.9 28.6 0 7.34 27 49
A T240 13:30 23 34 32 12 213 3 0.9 4.6 6.1 0.11 0.18 18 17 100 196 7 29 10 2.08 34 3 100 13.8 69.6 -3 7.36 49 40 Cy
V 14.8 30.9 -1 7.32 26 50
A T270 14:00 23 34 32 12 195 3 4.2 5.5 0.11 0.18 17 19 96 200 8 20 10 1.13 34 200 5 100 15.8 70.8 -2 7.35 48 43
V 14.7 21.8 -2 7.31 27 51
A T300 14:30 23 35 33 11 188 3 4.4 5.4 0.1 0.17 17 20 95 203 8 30 8 1.69 34.1 100 2 100 15.3 61.3 -2 7.33 49 46 Cy
V 14.9 25.4 1 7.33 29 48
A T330 15:00 23 34 32 12 190 3 4.5 4.9 0.13 0.16 11 23 99 207 8 34 11 1.66 34.1 100 3 1?? 14.6 65.9 -3 7.34 48 44
V 14.4 24.2 -1 7.3 26 38
A T360 15:30 23 34 32 12 184 3.2 4.5 4.7 0.1 0.15 14 34 94 216 8 26 8 1.61 34.2 25 1?? 14.5 66.2 -2 7.33 47 45 Cy+P/V
V 14.1 67.6 -2 7.29 25 38
V
A T375 Lung, Liver, Kidney Fix and F
V Bal spin and freeze
Notes:
4/27/2006
2359 control
Catheter leak Tween -> lost  ~60mL so added an additional 10mL to original 30mL close to RT Lung
Liquid edema filled the trachea tube at necropsy. It appeared to contain a great deal of plasma since it was "yellowish" and clotted.
BAL missed
Lung injury was excellent - very heterogenous injury - small atelactatic areas throughout lung
No bleeds lung inflation during necropsy similar to previous studies. In past studies belbs occurred not during the study but only when the lung was inflated out of the chest. Over expansion 
due to loss of the chest wall is an obvious answer, however, these lungs blebbed before the atelectasis was (??). Blebs popped up in both normal and atelectactic areas. In this
study, we inflated the lung (??) Pcontrol 5 and slow rises in PEEP. This slow type of inflation opened all of the atelectasis without causing blebs.
Appendix A (Cont'd)
02/02/06
Return to 12 cc/kg PEEP 3 for 15"  to check Blood Gases and Mechanics
Baseline and T0 are identical in control: no need for additional reading.  T0 in injury is immediately following injury.
Table 1.  Blood Chemistry Parameters
Variable Group T0 T30 T60
pH Control ND 7.47 ± 0.01 7.47 ± 0.03
5% Tween 7.38 ± 0.05 7.58 ± 0.31 7.40 ± 0.08
PCO2 Control ND 39 ± 0.5 39 ± 2.5
5% Tween 44 ± 6.0 42 ± 2.0 43 ± 7.0
BE Control ND 5 3.33
5% Tween 44 ± 6.0 42 ± 2.0 43 ± 7.0
Table 2.  Hemodynamic Parameters
Variable Group T0 T30 T60
PAP Control 13.5 26.3 ± 7.4 28.7 ± 7.0
5% Tween 12 ± 5.7 13.3 ± 1.4 14.3 ± 0.7
Ppw Control 8 7.7 ± 0.6 7.7 ± 0.6
5% Tween 16.7 ± 12 14.3 ± 9.2 14.7 ± 8.1
CO Control 3 2.8 ± 1.2 3.0 ± 1.3
5% Tween 3.7 ± 2.7 4.4 ± 0.6 3.2 ± 1.2
Table 3.  Pulmonary Parameters
Variable Group T0 T30 T60
Ppeak Control 23 21 ± 4.0 21 ± 3.6
5% Tween 31 ± 3.5 31 ± 0.6 31 ± 1.5
Pplat Control 20.5 18 ± 4.5 18 ± 3.5
5% Tween 27 ± 6.2 28 ± 3.2 28 ± 4.4
Compliance Control 16.2 23.9 ± 10.5 22.7 ± 9
5% Tween 11.6 ± 4 11.6 ± 2.9 10.4 ± 3
Table 1.  Blood Chemistry Parameters (Cont'd)
T90 T120 T150 T180 T210
7.46 ± 0.03 7.45 ± 0.03 7.44 ± 0.02 7.43 ± 0.02 7.41 ± 0.05
7.40 ± 0.08 7.42 ± 0.05 7.42 ± 0.05 7.42 ± 0.04 7.41 ± 0.04
40 ± 5.1 41 ± 2.1 43 ± 0.6 44 ± 4.2 42 ± 3.1
40 ± 2.6 39 ± 3.2 40 ± 4.0 39 ± 1.5 39 ± 2.1
2.67 2.67 2.67 2 2
40 ± 2.6 39 ± 3.2 40 ± 4.0 39 ± 1.5 39 ± 2.1
Table 2.  Hemodynamic Parameters (Cont'd)
T90 T120 T150 T180 T210
26 ± 9.5 29 ± 7.5 32 ± 8.7 33 ± 7.9 35.3 ± 4.5
13.3 ± 0 15 ± 2.1 15.7 ± 4.9 16.3 ± 0.7 20.3 ± 0.7
7.7 ± 1.5 7.3 ± 1.2 8.3 ± 1.2 8 ± 1 9 ± 1
12.7 ± 9 15.7 ± 11.6 19 ± 17.3 17.7 ± 15.1 13 ± 4
2.7 ± 1.1 2.5 ± 1.7 3.1 ± 0.9 2.4 ± 0.3 2.3 ± 0.2
3.6 ± 0.7 3.3 ± 1.1 3.5 ± 0.8 3.1 ± 1.1 2.8 ± 1.6
Table 3.  Pulmonary Parameters (Cont'd)
T90 T120 T150 T180 T210
21 ± 4.0 21 ± 4.4 22 ± 4.0 22 ± 4.9 20 ± 3.6
31 ± 3.8 33 ± 3.6 33 ± 3.2 33 ± 5.3 33 ± 4.9
19 ± 3.8 18 ± 4.0 20 ± 3.5 20 ± 4.6 18 ± 3.6
28 ± 5.5 30 ± 4.4 30 ± 4.7 30 ± 5.9 30 ± 7
23.7 ± 7.2 23 ± 6.4 20.5 ± 7 21.3 ± 5.1 24.2 ± 5.2
10.5 ± 3.5 10.6 ± 3.4 9.7 ± 3.4 10 ± 4.1 9.8 ± 4.4
Table 1.  Blood Chemistry Parameters (Cont'd)
T240 T270 T300 T330 T360
7.43 ± 0.05 7.43 ± 0.04 7.43 ± 0.03 7.43 ± 0.04 ND
7.41 ± 0.04 7.34 ± 0.10 7.37 ± 0.05 7.31 ± 0.12 7.41 ± 0.08
43 ± 4.4 41 ± 5.0 42 ± 3.2 41 ± 3.5 ND
39 ± 1.5 53 ± 24 42 ± 8.7 47 ± 8.8 38 ± 7.0
2 1.67 2 2.33 2
39 ± 1.5 53 ± 24 42 ± 8.7 47 ± 8.8 38 ± 7.0
Table 2.  Hemodynamic Parameters (Cont'd)
T240 T270 T300 T330 T360
34.7 ± 7.8 36 ± 6.6 38.3 ± 1.2 34.3 ± 3.1 35.5
19.7 ± 2.1 20 ± 1.4 21.3 ± 2.8 21 ± 2.1 20 ± 4.2
8.7 ± 1.2 8.7 ± 1.2 9 ± 1 9.3 ± 0.6 8.5
20 ± 12.7 16.5 ± 4.9 20 ± 14.1 22 ± 17 18.5 ± 10.6
2.5 ± 0.2 1.9 ± 0.3 2.1 ± 0.4 2.4 ± 0.3 2.1
2.7 ± 1.7 2.5 ± 1.9 2.0 ± 0.9 2.4 ± 1.3 1.8 ± 0.4
Table 3.  Pulmonary Parameters (Cont'd)
T240 T270 T300 T330 T360
22 ± 5.6 22 ± 4.6 23 ± 4.9 23 ± 5.3 22
33 ± 5.1 34 ± 8.5 34 ± 8.0 33 ± 5.6 33 ± 5.0
20 ± 4.7 19 ± 4.2 20 ± 4.9 21 ± 4.4 19
30 ± 6.7 32 ± 9.5 31 ± 7.8 30 ± 7.6 32 ± 5.5
23.3 ± 4.4 22.2 ± 4.4 21.8 ± 5 21.6 ± 4.9 24.2
10 ± 5 9.5 ± 5.4 10 ± 5.7 9.5 ± 5.3 9.3 ± 5.1

2 
 
 
ABSTRACT: 
  
Severe physical-trauma can lead to the development of acute respiratory distress 
syndrome (ARDS). Currently, the only known treatment for ARDS is mechanical 
ventilation. However, if mechanical ventilation is applied inappropriately further 
injury and malfunction of the lungs may occur, and thus, causing a ventilator 
induced lung injury (VILI). 
 
VILI has several manifestations including volutrauma, atelectrauma, and 
biotrauma. These mechanisms often exacerbate one another adding further insult 
to the injury. The goal of this current study is to establish a stable control pig 
model of ARDS as a comparison for ventilatory strategies that will act in a more 
protective manner than an injurious manner.  
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BACKGROUND: VENTILATOR-INDUCED LUNG INJURY 
 Mechanical ventilation has been used to support acutely ill patients for 
several decades. However, it has become apparent, especially to researchers and 
clinicians within the specialty, that even though there are many life saving 
benefits of mechanical ventilation, it also has several serious drawbacks. Recently 
a serious complication of mechanical ventilation known as ventilation induced 
lung injury (VILI) has been identified. Initially, the mechanisms of VILI  was 
believed to be barotrauma, which are gross tears that cause leakage of air into the 
thorax due to disruption of the epitheal cells that form the wall of the alveoli. This 
extra-alveolar accumulation of air can bring about several complications (1) the 
most threatening of which is a tension pneumothorax, or the accumulation of air 
in the pleural cavity. The adverse results of these macroscopic occurrences are 
usually immediately obvious, and macroscopic form of barotrauma has been the 
subject of clinical studies and the experimental studies of Macklin and Macklin 
(2).  
It was not until recently that microscopic pathologic damage was found to 
occur during improper mechanical ventilation of patients with acute respiratory 
distress syndrome (ARDS). This newly recognized form of injury is currently of 
major interest to researchers and clinicians caring for ARDS patients requiring the 
application of ventilatory support. Although several fundamental experimental 
studies were published prior to 1975, it wasn’t until 10 years later that renewed 
interest in VILI stimulated a major research effort (3). Unlike the belief that gross 
barotrauma (i.e., gross tearing of the lung) was the primary mechanism of VILI, 
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the contemporary belief is that microscopic damage to the pulmonary parenchyma 
is the major mechanism of VILI (4). These microscopic injuries cause increases in 
endothelial and epithelial permeability leading to alterations in lung fluid balance. 
The microscopic injury observed for VILI (5) does not have specificity. In other 
words, the injury due to VILI has a similar pathology compared to other 
pulmonary injuries. Thus, the non-specific pathological outcome of VILI makes it 
difficult to discern a pulmonary injury solely as a result of VILI or another 
mechanism. It similarly approximates the injury that can be observed in additional 
models of acute lung injury (6). The pathophysiology of VILI does not differ 
significantly from the disperse injury of alveoli observed during ARDS (7). 
Therefore, VILI is indistinguishable from the initial respiratory failure, which the 
ventilator is attempting to treat. The concept that mechanical ventilation can truly 
bring about further aggravation of pre-existing acute lung disease is now widely 
acknowledged (8). Any demonstration of VILI superimposed over the pulmonary 
disease (i.e. ARDS) would be illusive. Thus, this concept derived from animal 
studies has resulted in complete reassessment of the use of mechanical ventilation 
for patients with acute lung diseases and underlies current trends; such as 
ARDSnet and HFO ventilatory strategies, in the clinical practice of mechanical 
ventilation (9). Indeed, the current orientation is to emphasize the potential 
importance of easing the stress on acutely injured lungs by using modes of 
ventilation that limit the pressure and volume of gas delivered to the lungs (10-
11). 
ACUTE RESPIRATORY DISTRESS SYNDROME  
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 Acute Respiratory Distress Syndrome (ARDS) is an acute, severe injury to 
most or all of both lungs. Patients with ARDS experience severe shortness of 
breath and often require mechanical ventilation, because of respiratory failure. 
ARDS is not a specific disease, instead, it is a type of severe, acute lung 
dysfunction and it is associated with a variety of diseases, such as pneumonia, 
shock due to sepsis; which is a severe infection in the body, and trauma. ARDS 
can be confused with congestive heart failure, which is another common condition 
that can also cause acute respiratory distress.  
 At the onset of ARDS, lung injury may first appear in one lung, but then 
quickly spreads to affect most of both lungs. When alveoli are damaged, some 
collapse and lose their ability to receive oxygen. With some alveoli collapsed and 
others filled by fluid, it becomes difficult for the lungs to absorb oxygen and get 
rid of carbon dioxide. Within one or two days, progressive interference with gas 
exchange can bring about respiratory failure requiring mechanical ventilation. As 
the injury continues over the next several days, the lungs fill with inflammatory 
cells derived from circulating blood and with regenerating lung tissue. Fibrosis, or 
the formation of scar tissue, begins after about 10 days and can become quite 
extensive by the third week after onset of injury. Excessive fibrosis further 
interferes with the exchange of oxygen and carbon dioxide.  
Knowledge of the cause of ARDS is not well defined. Current information 
supports several theories about its development, but the precise reason ARDS 
occurs remains unknown. What is known, however, is that the onset of ARDS can 
come about by one of two basic mechanisms. The first is a direct physical or toxic 
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injury to the lungs. Examples include inhalation of vomited stomach contents, 
smoke or other toxic fumes, and a severe “bruising” of the lungs that usually 
occurs after a severe blow to the chest. The second mechanism is more common, 
but less understood. This is an indirect, blood initiated injury to the lungs. When a 
person is extremely sick or the body is severely injured, cytokines and other 
signals are released into the bloodstream. These signals reach the lung, and the 
lung becomes overwhelmed by an inflammatory response, thus causing lung 
dysfunction. Examples of this type of indirect lung injury include the presence of 
sepsis and severe injury - the two most common factors in ARDS cases (12). 
THE ALVEOLI 
An alveolus sac is the point where gas exchange occurs within the lung; 
typically carbon dioxide is exchanged for oxygen. About 300 million alveoli are 
located within a normal, human lung. In addition, each alveolus has a diameter of 
about 250μm and is enveloped by as many as 1000 capillaries. A rough 
estimation for the area of contact between the alveoli and the capillaries has been 
in the range of 50 to 100 meter2. This large area allows for the exchange of 
oxygen and carbon dioxide through the process of diffusion from higher areas of 
concentration to areas of lower concentrations. This provides for an excellent 
example of the natural phenomena of a large surface area being placed within a 
relatively small volume of space. 
 The surface of an alveolus sac is composed of a single layer of epithelial 
cells, which compose about 93% of the alveoli surface area; type I alveolar cells. 
Found amongst the type I cells, the larger cells that produce the fluid layer lining 
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the alveoli are known as type II alveolar cells. Additionally, a phagocyte can be 
found within the extracellular fluid lining of the alveolar surface providing for 
primary immune defense. 
THE PHYSIOLOGICAL BASICS OF THE LUNG 
 The exchange of gases between the air located outside the alveoli and air 
within the alveoli is known as ventilation. Commonly known, air moves from a 
region of higher pressure to a region of lower pressure. 
F = ΔP / R 
This is known as the flow of air (F) is equivalent to the difference in pressure 
(ΔP) among two different regions, and the resistance(R) experienced by the air 
decreases the flow of air. Concerning the issue of the flow of air into and out of 
the lungs, the pressure inside the alveoli sacs themselves is known as the alveolar 
pressure (Palv), and the atmospheric pressure (Patm) are of significance. 
F = (Patm - Palv) / R 
Over the course of ventilation, air moves into and out of the lungs because the 
alveolar pressure is alternating between pressures less than and greater than that 
of the atmospheric pressure. The change in alveolar pressure is caused by changes 
in the volume of the chest wall and lungs. 
 To understand this concept, it is essential to know Boyle’s law  
P1V1 = P2V2
During inspiration, for example, the diaphragm lowers and the chest extends 
creating a larger volume for the lungs to occupy, and thus decreasing the pressure 
within the lung. This change from a higher to lower pressure causes air to flow 
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into the lungs, and vice versa during expiration. 
 The surface of the alveoli cells is moist, and so the alveoli can be thought 
of as air filled sacs externally lined with water. At an air-water interface, the 
attractive forces between water molecules, known as surface tension, cause the 
water molecules composing the water lining to form a pulling force amongst each 
other. An excellent demonstration of this would be adding water drop by drop 
onto the surface of a penny. If carefully done a bubble of water will form and 
maintain its form as long as it is not greatly disturbed. Essentially, to expand the 
lung, energy is required not only to stretch the connective tissue of the lung, but 
also to overcome the surface tension of the fluid layer lining the alveoli.  
 The role of type II alveolar cells is to prevent the fluid layer lining the 
alveoli from becoming a great force to be overcome during lung expansion, which 
could potentially lead to the collapsing of alveoli sacs. Type II alveolar cells 
secrete a substance similar in nature to detergent molecules, known as pulmonary 
surfactant, and these molecules greatly reduce the cohesive forces between water 
molecules on the alveolar surface by disrupting their molecular interactions, such 
as hydrogen bonding and van der Waals forces. Therefore, surfactant is able to 
decrease the surface tension that would otherwise be a greater force to overcome. 
The presence of surfactant is essential to lung compliance and allows the lungs to 
expand with greater ease. 
 Pulmonary surfactant is a complex of both lipids and proteins, however 
it’s mostly composed of phospholipids consisting of both a hydrophilic tail and a 
hydrophobic head and these act by forming a monolayer between the air and 
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water at the alveolar surface. During times of non-strenuous, consistent breaths, 
the concentration of surfactant has a tendency to decrease, since there is a smaller 
tidal volume, and with it a less dynamic change, in the lung tissue itself. However, 
a deep breath causes the type II alveolar cells to be stretched and in turn 
stimulates the secretion of surfactant by these cells as well. The Law of Laplace: 
 P = 2T / r 
shows the relationship between pressure (P), surface tension (T), and the radius 
(r) of an alveolus. As the inner radius of the alveolus decreases, the pressure 
increases. For two alveoli next to each other sharing alveolar duct, the inner 
radius of the alveoli is larger than the other. If the surface tension (T) is equal for 
both alveoli, the alveolus with the smaller radius would have a higher pressure 
according to the Law of Laplace. And if pressure of alveolus with the smaller 
radius is higher than pressure of alveolus with a larger radius then air will flow 
from the alveolus with a smaller radius to the alveolus with a larger radius. This 
will lead the alveolus with a smaller radius to collapse (13). Thus, alveoli with 
smaller radii are more unstable and are more likely to collapse into larger alveoli.  
Taking the radii of alveoli into consideration, it is appropriate to attend to 
an additional property of surfactant which is its ability to stabilize alveoli of 
different sizes by altering surface tension, depending on the surface area of the 
alveolus. When an alveolus becomes smaller, the molecules of surfactant on its 
surface are more concentrated since more molecules of surfactant are spread 
across a smaller area, thus reducing the surface tension. This reduction in surface 
tension aids a smaller alveolus to maintain a pressure equal to that of a larger 
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alveolus (13). Thus, surfactant acts to stabilize alveoli of different size. 
TYPES OF VENTILATOR-INDUCED LUNG INJURY 
 Definitive evidence that mechanical ventilation can cause damage to the 
lungs in humans is difficult to obtain, since it is clearly not possible to perform 
experiments in which humans are exposed to strategies of ventilation that are 
thought to be injurious, solely for the purpose of examining the lung injury that it 
can cause. Thus, the injuries known as ventilator-induced lung injury (VILI) can 
be thought of as correlating with ventilator maneuvers, since no definitive cause 
and effect relationship can truly be distinguished as of now. However, the 
evidence obtained from experimental animal studies and correlative human 
studies, and other studies focusing on the side effects of different ventilatory 
parameter manipulations have become swayed and are joining the band wagon 
that this matter of concern is a priority for critical care clinics.  
Barotrauma 
 The concept that high airway pressures during positive pressure 
ventilation can cause a massive injury in the form of air leaks, known as 
pneumothorax, has been well known and investigated for many years. However, 
the issue that has not been clear as night and day is which pressure parameters; 
such as peak, mean, PEEP, etc., are of utmost significance and the exact values at 
which these pressure parameters induce VILI. However, it has become clear that 
the absolute airway pressure alone does not directly bring about the injury. Even 
though it is a modality for airway pressures to be monitored clinically, 
transpulmonary (alveolar pressure minus pleural pressure) pressures are of greater 
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significance. This can be better understood by the observation that very high 
airway pressures can often be achieved, however, the presence of barotrauma is 
rather uncommon (14). The attribute of utmost significance in the development of 
pneumothorax appears to be the degree with which different regions of the lung 
are distended. 
Volutrauma 
 In addition to the obvious manifestations of overdistention previously 
discussed, an even more inconspicuous injury can be induced by mechanical 
ventilation. Webb and Tierney (15) produced strong evidence that overdistention 
associated with high peak airway pressures could lead to the development of 
pulmonary edema and the death of rats within 1 hour. Since this study, a large 
number of investigators have observed that high end inspiratory lung stretch could 
inflict diffuse alveolar damage, the formation of pulmonary edema, an increased 
fluid filtration, an increased epithelial permeability, and an increased pulmonary 
capillary permeability. It has been demonstrated by Egan et al. (16) that static 
inflation of sheep lungs up to pressures of 40 cm H2O leads to an increase in pore 
radius of a magnitude that potentially allows fluid to leak into the alveoli. In 
addition, Parker et al. (17) performed ventilation on isolated dog lungs for 20 
minutes and noted that peak pressures of more than 20 cm H2O lead to an increase 
in capillary filtration correlating with the increase of peak pressure. 
 Hence, Dreyfuss et al. (18) came up with the term volutrauma. This is 
pertinent as to indicate that the cause of injury was not exclusively due to airway 
pressure, but rather to the volume. In this study rats were grouped to undergo one 
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of three ventilatory strategies: high pressure and high tidal volume which was 
found to lead to an increase in lung water; an application of low pressure and high 
volume for which the rats underwent negative pressure ventilation of high tidal 
volumes also leading to an increase in lung water; and lastly, a strategy of high 
pressure and low volume calling for the chest walls of the rats to be strapped 
down over the course of ventilating them with high pressures and low tidal 
volumes even though there was a decrease in compliance, the lung water was 
within the expected range for rats (18). Thus, further supporting the theory that 
lung volume was the significant factor in inducing increased lung water in 
opposition to pressure. In further studies of rats,  Dreyfuss et al. (19)showed that 
the time course of such injury was very rapid, with more than a 50% increase in 
lung water within 20 minutes. The rapid progression with which this degree of the 
lung injury was achieved was further exacerbated if the high tidal volumes were 
decreased reasonably quickly. Expanding upon this study, Dreyfuss and 
colleagues (20) were able to show that an interaction between pre-existing acute 
lung injury (ALI) and mechanical ventilation did exist. This was accomplished 
through a study in which an injury model called for the lungs to be damaged with 
alpha-naphthyl-thiourea (ANTU). A combination of both injurious factors of high 
volume and ANTU had a synergistic effect by increasing extravascular lung 
water(20). 
 An endless array of mechanisms have been proposed to account for this 
increase in alveoli and pulmonary capillary permeability that is observed with the 
application of high tidal volume ventilation. For instance West et al. (21) have 
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conducted elaborate studies with the proposal of wall stress failure as a 
mechanism. The build up of excessive wall stress is a dependency of stress 
failure; it is the ratio of alveolar wall tension to the thickness of the alveolar wall. 
To demonstrate, Fu et al. (22) showed that at a constant transmural pressure, an 
increase in transpulmonary pressure from 5 to 20 cm H2O produced a significant 
increase in the number of breaches within the epithelial and endothelial cell 
layers. Moreover, it was found that a further increase in the occurrence of cell 
layer breaks while transpulmonary pressure was held constant and when the 
pressure across the capillary wall was further increased. 
 Although these mechanical factors causing the cellular damage are 
important, a recent study by Parker et al. (23) suggests that increased permeability 
due to VILI may be caused by a much more subtle mechanism. These 
investigators examined the hypothesis that microvascular permeability might be 
actively altered by a cellular response to mechanical injury, and that this response 
might be initiated by stretch-activated cation channels through increases in 
intracellular calcium concentration. The results show that the coefficient for 
capillary filtration increased 3.7 fold that at baseline in lungs ventilated with a 
peak airway pressure of 35 cm H2O, which was unchanged from the baseline 
when the lungs were ventilated under the same ventilatory parameters. 
Atelectrauma 
 In addition to the injury caused by ventilation at high lung volumes, there 
is a collective amount of evidence indicating that ventilation at low lung volumes 
may contribute to injury as well. This injury is believed to be related to the 
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continuous opening and closing of the alveoli sacs. This concept of injury caused 
by the repetitive opening and collapse of distal airways was first proposed by 
Robertson et al. (24) to explain the lung injury observed in infants with 
respiratory distress syndrome (IRDS). The results of the study suggested that in a 
lung undergoing atelectasis, the air-liquid interface may be located relatively 
close to the ending tips of the airways, rather than at the alveoli themselves. To 
open the airway with such an air-liquid interface would require a relatively high 
pressure. And in the process of opening the air way, the shear stress experienced 
by the airway duct may lead to the disruption of epithelial cells lining the airway 
duct. The evidence that lung injury can be caused by ventilation at low lung 
volumes has been collected across studies using different species (such as rats, 
rabbits, and dogs), different lung injury models (saline lavages and ventilator-
induced lung injuries), and examined by the use of different ventilatory strategies 
(such as differing PEEP settings and different mechanical ventilators like high-
frequency oscillation (HFO)) (25-26). 
 The comparison of conventional mechanical ventilation with HFO has 
been done across numerous studies (27). For these studies, rabbits that were 
ventilated with HFO had a greater concentration of oxygen over the course of the 
study and a decrease in lung injury was accounted for through pathological 
analysis showing hyaline membrane formation, which is representative of 
insufficient surfactant concentrations. Further, McCulloch et al. (28) found that 
the beneficial effect was not solely due to HFO itself, but in addition, 
interdependent interactive effects exist concurrently with the mean airway 
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pressure and the mean lung volume. Rabbits that were ventilated at low mean 
airway pressures manifested a significantly greater degree of lung injury than the 
rabbits ventilated at a higher mean airway pressure, even though both of the 
groups were ventilated with HFO.  
Additional studies using conventional mechanical ventilation reported 
similar findings that high mean lung volume ventilation appeared to be protective 
with different levels of PEEP (29). Most of these studies were in vivo models, 
which prove to be advantageous through the utilization of intact animals, and thus 
provide for a model with a higher degree of external validity for clinical 
application. However, a problem that arises with the use of such a model is the 
difficulty of maintaining the same, if not similar values for partial pressure of 
oxygen (PaO2), fraction of inspired oxygen (FiO2), and arterial blood pressures 
amongst the individual animals within each treatment group. Unfortunately, this 
can make interpretation and application of the data from these studies more 
challenging, especially when trying to distinguish amongst the direct mechanical 
effects of ventilation on the lung and the other indirect factors. To circumvent this 
obstacle, Muscedere et al. (26) utilized an ex vivo, non-perfused rat lung system. 
In this study, it was observed that the application of PEEP above the inflection 
point of alveolar recruitment and derecruitment, will significantly reduce the rate 
at which the lung compliance will decrease. A decrease in lung compliance is 
typically observed with lower PEEP level applications. Further, it was also found 
that less pathologic typical attributes of lung injury were observed when assessing 
by airway injury and the formation of the hyaline membrane. Results from this 
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particular model need to attend to the fact that the degree of recruitment and 
derecruitment is interacting synergistically, because there is no chest wall and 
thus at a PEEP of 0, the transpulmonary pressure is going to be 0. However, this 
is not the case in vivo. 
 In addition to the recruitment and derecruitment discussed, a number of 
other possible mechanisms exist that can lead to the development of lung injury 
with low lung volume ventilation. The extent to which the alveoli collapse or 
become filled with fluid, will correspond with a decrease in alveolar PaO2 that can 
permanently damage cells. Ventilation at low lung volumes can also lead to the 
inhibition of surfactant production and lead to surfactant being squeezed out of 
the alveoli. In addition, the re-recruitment of atelectatic regions of complete 
alveolar collapse to the fully recruited regions has been found to be associated 
with the further insult to the areas under regional stress. Mead et al. (30) proposed 
that an unexpanded lung region completely dispersed amongst regions of 
expanded lung would experience a pressure much greater than the transpulmonary 
pressure. This has the potential to cause significant, local amplification at 
pressures that lead to the overdistension of the alveoli.  
Biotrauma 
 The previously discussed types of injury are largely thought to be 
mechanical injuries brought about by mechanical factors. However, in more 
recent years, there has been increasing evidence that mechanical factors can lead 
to injury that is cell and inflammatory mediator based, with a greater emphasis on 
the biological mechanisms of injury, which is the mechanism of injury known as 
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biotrauma (31). 
 Numerous studies have found that the mechanical ventilation of injured 
lungs could lead to a further injury that is an inflammatory response. Kawano et 
al. (32) studied rabbit lungs that were injured by the administration of a lavage 
and were conventionally ventilated. The study showed that the animals developed 
severely depleted levels of oxygen, and the histological analysis revealed that a 
large number of neutrophils were found within the lung, whereas animals that 
were neutrophil depleted by treatment with nitrogen mustard which is a toxic 
compound, prior to the lung lavage had significantly better oxygenation. The 
investigators suggested that cytokines released from neutrophils played a crucial 
role in VILI. Further, Imai et al. (33) compared conventional mechanical 
ventilation with HFO in a lung lavage model and observed that HFO was 
associated with a large decrease in the amount of neutrophils, cytokines, and other 
cellular immune signals in the lung lavage, including platelet-activating factor. 
 Most of these studies have been performed in animal models which have 
limitations when attempting to apply the findings to human, clinical treatments. A 
clinical study conducted by Amato et al. (34) examined if a ventilatory strategy 
that was aimed at minimizing lung injury would decrease the mortality of patients 
with ARDS. They studied 53 patients who were assigned at random to receive a 
protective ventilatory strategy consisting of recruitment, high levels of PEEP, and 
pressure limitation at end-inspiration compared with a control group that received 
conventional mechanical ventilation. The findings showed that the patients who 
underwent the protective ventilatory strategy had a mortality rate of 38% in 
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comparison to the 71% mortality rate of the control group. Further, a National 
Institutes of Health - National Heart, Lung, and Blood Institute trial study showed 
that the utilization of a tidal volume of 6 mL/kg lead to about a 25% decrease in 
mortality compared to 12 mL/kg tidal volume in patients with ARDS (35). One 
proposed mechanism to account for the significant decrease in mortality was 
proposed through a study by Ranieri et al. (36) for which two similar ventilatory 
strategies were used and it was found that the group treated with a minimal tissue 
stress strategy had a decrease in the concentration of cytokines compared to the 
control group. 
 Further, other studies have led to the speculation that injurious strategies 
of mechanical ventilation could lead to the development of multisystem organ 
failure (MSOF) (37). If this is the case, it could help better account for the high 
mortality rate of patients with ARDS and more importantly could lead to 
additional modifications for ventilatory strategies and interventions in critically ill 
patients which may in turn lead to a decrease in mortality. 
PULMONARY EDEMA 
 Pulmonary edema is the accumulation of fluid in the lung. This pathology 
may be induced by a number of physiologic abnormalities, which ultimately result 
in impaired gas exchange. The edema first accumulates in the interstitial and then 
the alveoli, as edema accumulation progresses it causes a decrease in gas 
exchange, especially oxygen. This due to the fact that the capillary epithelium has 
a greater permeability of water than the alveolar epithelium.  
Lymph Drainage from the Lung. 
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 Fluid that reaches the pulmonary interstitial can only be removed by the 
lymphatic connection of the lung. It is now believed that the volume of lymph 
flowing from the lung is as great as that of any other organ in the human body. 
The lymph drainage also is believed to achieve a rate 10 fold the normal drainage 
volume during pathologic conditions. When the lymphatic drain is overwhelmed, 
however, the accumulation of pulmonary edema can compromise the well being 
of an individual. 
 There are a number of conditions that can lead to the development of 
pulmonary edema. Factors that bring about the destruction of the capillary 
endothelium such as infection or toxin, can cause localized pulmonary edema 
(13).   
LUNG COMPLIANCE 
 The lungs are organs that are characterized by elasticity and have the 
ability to retain their initial shape after being stretched. Lung compliance (CL) is 
defined as the amount of change in lung volume (Δ VL) induced by a given change 
in the transpulmonary pressure.  
   CL = Δ VL /  Δ (Palv - Pip) 
Thus, the greater the lung compliance, the easier it is to expand the lungs at any 
given change in transpulmonary pressure. Compliance is basically the inverse of 
stiffness. Thus, a low value of lung compliance will require a greater than normal 
transpulmonary pressure to be established across the lung in order to cause given 
amount of lung expansion.  
 Two determinants of lung compliance are stretch ability and surface 
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tension at the air-water interface among alveoli. Stretch-ability of the lung tissue 
itself, particularly the elastic connective tissues, can have an affect on lung 
compliance. Thus, a thickening of lung tissue decreases the lung compliance. The 
accumulation of edema and neutrophils may act to decrease the compliance of the 
lung through a tissue thickening mechanism. The compliance of the lung is also 
dependent in part upon the concentration of surfactant and the accumulation of 
extracellular fluid acts to decrease the concentration of the surfactant molecules 
on the alveoli. 
RESEARCH PERFORMED IN THE DEPARTMENT OF 
SURGERY OF THE STATE UNIVERSITY OF NEW YORK – 
UPSTATE MEDICAL UNIVERSITY 
INTRODUCTION: 
 As mentioned previously, severe physical-trauma can lead to the 
development of acute respiratory distress syndrome (ARDS). Currently, the only 
known treatment for ARDS is mechanical ventilation. If a patient is connected to 
a mechanical ventilator at inappropriate settings, however, further injury and 
malfunction of the lungs may occur, and thus, causing ventilator induced lung 
injury (VILI). The global goal of this research is focused on reducing or even 
eliminating VILI for patients on mechanical ventilation. The lab believes this goal 
can be achieved through defining the ideal mechanical ventilatory parameters 
specific to ARDS-like states as well as other factors, such as kinetic application, 
non-native surfactant administration and the prevention of degradation of 
intercellular lung, protein adherins, which may offer additional protective 
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advantages; either act independently or have a synergistic effect.  
 In order to develop these ideal ventilatory strategies a relatively stable, in 
vivo model that can be translated to human applicability must be established. 
Thus, the focus of the current research is to establish a reliable model of ARDS in 
pigs, since pigs have a similar respiratory and circulatory system to humans. Two 
current, protective modes of ventilation high frequency oscillatory ventilation 
(HFOV) and adaptive pressure release ventilation (APRV) in congruence with the 
current clinically-utilized standard of care method of ventilation established by 
the ARDS Network (ARDSnet) will be compared with the progress of this 
particular study. 
 In an ARDS model caused by tween, which is a detergent that deactivates 
pulmonary surfactant, application of non-protective ventilation group will exhibit 
many symptoms of ARDS compared to the control pigs that are ventilated without 
the establishment of any injury to the lungs. Thus, it is predicted that the pigs in 
the non-protective ventilation treatment will exhibit larger amounts of pulmonary 
edema, a higher concentration of collapsed alveoli, more evidence of an 
inflammatory response, and will exhibit lower concentrations of PaO2 as a result 
of a decreased surface area for gas exchange.  
MATERIALS AND METHODS: 
Animal Preparation 
 Six female Yorkshire pigs were anaesthetized by an animal care specialist 
at SUNY Upstate Medical University approximately 15 minutes before 
intubation. Continued anesthesia was administered on a need-basis using two mg 
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per kilogram of xylazine. Once secure intubation was established the pigs were 
continually ventilated at a pre-calculated volume. The surgical technician and the 
physician cannulated the pig’s right internal jugular vein and the right carotid 
artery under sterile conditions. Baseline measurement and the fractional inspired 
oxygen (FiO2) was room air (21% O2). 
 After the catheters were secured in place, the following baseline measures 
were recorded for the heart rate (HR), respiratory rate (RR), temperature (°C), 
arterial pressure, arterial blood gases (ABGs), and venous blood gases (VBGs). In 
addition, a Foley catheter was inserted into the bladder to measure urine output. 
Blood samples were collected hourly to measure the concentrations of plasma 
cytokines and proteases at baseline that were compared with plasma samples 
following injury to elucidate the inflammatory response.  
Non-injurious Protocol 
After the surgical preparation mentioned above, the pigs (n=3) will be 
ventilated at a tidal volume (Vt) of 12 mL/kg and a positive-end expiratory 
pressure (PEEP) of 3 cm H2O over the course of each 6 hour study. Parameters 
such as hemodynamic, lung function, ABGs, and VBGs measures will be 
recorded every 30 minutes. Arterial blood samples (30 mL) will be drawn hourly 
for plasma cytokine and matrix metalloproteinase measurements. Blood samples 
will be injected into six vacuum sealed test tubes and spun in a centrifuge for 10 
minutes at 3500 RPM at 15°C. The upper plasma layer of the freshly spun, blood 
samples were carefully aliquotted into eight, 2 mL cryo-vials and submersed 
within liquid nitrogen to immediately freeze the samples for storage. 
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At necropsy, the lung was fixed for histologic analysis, edema will be 
assessed by wet/dry weight ratio (W/D), and bronchoalveolar lavage fluid 
(BALF) will be sampled for protein concentration, cytokine and protease analysis, 
7S Fragment concentration and surfactant function. 
Injury with Non-protective Ventilation Protocol 
Similar to the protocol for non-injurious, control group, after the surgical 
preparation, the pigs (n=3) will be ventilated at a tidal volume (Vt) of 12 mL/kg 
and a PEEP of 3 cm H2O initially. Parameters such as hemodynamic, lung 
function, ABGs, and VBGs measures will be recorded every 30 minutes. Arterial 
blood samples (30 mL) will be drawn hourly for plasma cytokine and matrix 
metalloproteinase (MMP) measurements.  
Lung injury (ARDS) was caused by the instillation of the 5% 
Tween/Saline by lavage. PEEP was increased to 10 cm H2O and peak inspiratory 
pressure (PIP) was adjusted to 35 cm H2O during and for 10 minutes post tween 
instillation. The pig was tilted on its right side for the instillation of half of the 
Tween dose into the lung with a suction catheter. The suction catheter was moved 
in and out approximately 6 cm over the course of the instillation to try to assure 
that the Tween was not instilled into only a single lobe. Post-instillation, the pig 
was kept on its right side for 10 minutes under the ventilatory parameters of Vt of 
12 mL/kg and PEEP of 10 cm H2O, PIP of 35 cm H2O. After the 10 minute 
period, the pig was laid on its left side and the procedure just discussed was 
repeated for the second half of the Tween instillation. Following tween instillation 
the pig was returned to the supine position and the PEEP returned to 3 cm H2O. 
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Mechanical ventilation was resumed with a Vt of 12 mL/kg and PEEP of 3 cm 
H2O and this was determined as time zero (T0). 
Pulmonary Edema 
 To determine if pulmonary edema was present within the lung, sections 
from each lobe of the lung was incised. Each sectioned piece of lung was placed 
within a pre-weighed dish and weighed; this provides what is known as the wet 
weight of the lung, which will be increased if the lung is edematous. The pre-
weighed dish containing the lung was then placed in an oven at 65°C for a period 
of 24 hours, and was weighed again. This process was repeated until no weight 
change was observed over the course of the 24 hour period, so the lung samples 
were determined to be dry. The fluid (edema) within the lung was determined to 
be equivalent to the wet-to-dry weight ratio (W/D). 
Histology 
 Histology was carried out to assess the lungs for pathologic injury. First, 
the lungs were instilled and immersed with formalin for a minimum of 48 hours. 
Two tissue samples were sectioned from the left lung; one dependent and one 
non-dependent position. The right lung will be used for histological analysis and 
the left lung will be used for cytokine and cellular analysis. To accomplish this, 
the trachea was cannulated while the left bronchiole was clamped-off, so that the 
right lung was able to be instilled with formalin to a fixed pressure of 20 cm H2O 
for 60 hours. The lung was then incised horizontally from posterior to anterior 
positions at a thickness of one centimeter. And from each section, two cubes of    
1 cm3 size are selected at random; one from the upper and from the lower portion. 
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Further, three slices of 5 μm thickness from each of the cubes was embedded in 
paraffin wax and hematoxylin-and-eosin staining was done for cell detection and 
measurement.  
RESULTS: 
Appendix A contains all of the individual data sheets for each of the pigs used in 
the study. 
Appendix B contains the compiled blood chemistry, hemodynamic, and 
pulmonary parameter data in tables 1, 2, and 3, respectively. Table 1 consists of 
arterial blood pH, partial pressure of carbon dioxide (PCO2), and base excess 
(BE), which is the amount of acid (in mmol/L) required to return the blood pH of 
an individual to the normal value. Table 2 consists of the mean pulmonary arterial 
blood pressure (PAP), pulmonary wedge pressure (Ppw) which is used to measure 
the back pressure from the pulmonary veins, and cardiac output (CO) is the 
volume of blood being pumped by the heart per minute (in L/min). Table 3 
consists of the peak airway pressure (Ppeak), plateau pressure (Pplat), and lung 
compliance (compliance). All the data values are expressed as the mean 
plus/minus standard deviation (mean ± SD).  
Appendix C contains the graphs of all the parameters measured over the course of 
the study. Figure 1 shows that the pigs in the non-protective ventilatory group had 
a pH that fluctuated near the beginning and the end of the studies compared to the 
control. Figure 2 the partial pressure of CO2 remained relatively stable and 
similar for both groups. Figure 3 the BE of the non-protective ventilatory group 
was lower compared to the BE of the control group. Figure 4 the mean pulmonary 
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pressure increased at a higher rate over the course of the study for the non-
protective ventilatory study compared to the control group. Figure 5 the mean 
Ppw was greater and fluctuated more in the non-protective ventilatory group 
compared to the control group. Figure 6 the mean CO for both groups decreased 
at a similar rate; however, the mean CO remained slightly greater in the non-
protective group compared to the control group. Figure 7 the MAP was parallel 
among the two groups; however, the MAP of the control group was greater 
compared to the non-protective ventilatory group. Figure 8 the mean Ppeak was 
greater in the non-protective ventilatory group compared to the control group. 
Figure 9 the mean Pplat was higher for the non-protective ventilatory group and 
increased over the course of the study, while the end Pplat control group remained 
relatively stable and equal to its initial Pplat. Figure 10 the lung compliance 
dramatically increased within the first 30 minutes post tween administration and 
remained relatively stable for the remainder of the study. However, the lung 
compliance of the non-protective ventilatory group decreased a small amount over 
the course of the study. 
Appendix D consists of photographs of gross and microscopic pathogical 
outcomes of both the control and non-protective ventilatory groups. Figure 11 is 
the photograph of a gross, excised lung from a pig in the control group. The lung 
exhibits homogeneity and is healthy in appearance. However, Figure 12 is the 
photograph of a gross, excised lung from a pig in the non-protective ventilatory 
group and exhibits great morphology compared to the control group pig’s lung. 
Figure 13 is a histological photograph of a pigs lung tissue from the control group 
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and the histopathology of this tissue shows the healthy thin walls of the alveoli. In 
comparison, Figure 14 is a histological photograph of a pig’s lung tissue from the 
non-protective ventilatory group. A clear distinction exist between the two 
histological slides. The histopathology of the pig from the non-protective 
ventilatory group shows that a thickening of the alveolar walls has occurred, as 
well as an accumulation of extracellular fluid (edema) and immune cells. 
CONCLUSIONS: 
 
 The high level of constancy among animals within each of the treatment 
groups shows that this model of ARDS can reliably be reproduced in different 
subjects. The differences observed of the blood chemistry, homodynamic, and 
pulmonary parameters can be easily observed on the graphs of Appendix C. The 
tell-tale signs of ARDS, such as a lower BE, increased pulmonary pressure, and a 
decrease in lung compliance, are clearly demonstrated by the experimental group 
in comparison to the control group.  
 By establishing this stable model of ARDS, further research into VILI as 
well as other respiratory illnesses can be accomplished with great validity. Future 
studies will be able to rely upon the stability of this ARDS model, so the 
differences observed among groups undergoing different treatment conditions will 
be truly the result of the treatment differences. Once an effective treatment has 
been established through bench work then this research can be further be 
introducing the methods through clinical studies. Eventually, research concerning 
ARDS and VILI may be defined enough to help dramatically decrease the high 
rates of morbidity and the mortality of today. And there is even the possibility of 
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eradicating VILI altogether. 
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Appendix C 
 
Figure 1. 
Mean pH of Control vs. Non-protective Ventilatory Groups
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Figure 2. 
Mean PO2 of Control vs. Non-protective Ventilatory Groups
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Figure 3. 
Mean Base Excess of Control vs. Nonprotective Ventilatory 
Groups
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Figure 4. 
Mean Pulmonary Arterial Pressure of Control vs. Nonprotective 
Ventilatory Groups
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Figure 5. 
Mean Pulmonary Wedge Pressure of Control vs. Non-protective 
Ventilatory Groups
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Figure 6. 
Mean Cardiac Output of Control vs. Nonprotective Ventilatory 
Groups
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Figure 7. 
Mean Arterial Pressure of Control vs. Non-protective Ventilatory 
Groups
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Figure 8. 
Mean Peak Pressure of Control vs. Non-protective Ventilatory 
Groups
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Figure 9. 
Mean Plateau Pressure of Control vs. Non-protective 
Ventilatory Groups
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Figure 10. 
Mean Lung Compliance of Control vs. Non-protective 
Ventilatory Groups
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